Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma—evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2018;15(2):95–111. https://doi.org/10.1038/nrclinonc.2017.157.

Article  CAS  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

Article  CAS  PubMed  Google Scholar 

Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi C, Calvisi DF, Perugorria MJ, Fabris L, Boulter L, Macias RIR, Gaudio E, Alvaro D, Gradilone SA, Strazzabosco M, Marzioni M, Coulouarn C, Fouassier L, Raggi C, Invernizzi P, Mertens JC, Moncsek A, Rizvi S, Heimbach J, Koerkamp BG, Bruix J, Forner A, Bridgewater J, Valle JW, Gores GJ. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557–88. https://doi.org/10.1038/s41575-020-0310-z.

Article  PubMed  PubMed Central  Google Scholar 

Valle JW, Borbath I, Khan SA, Huguet F, Gruenberger T, Arnold D. ESMO guidelines committee. biliary cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27:v28–37. https://doi.org/10.1093/annonc/mdw324.

Article  CAS  PubMed  Google Scholar 

Rimini M, Loi E, Fabregat-Franco C, Burgio V, Lonardi S, Niger M, Scartozzi M, Raposelli IG, Aprile G, Ratti F, Pedica F, Verdaguer H, Rizzato M, Nichetti F, Lai E, Cappetta A, Macarulla T, Fassan M, De Braud F, Pretta A, Simionato F, De Cobelli F, Aldrighetti L, Fornaro L, Cascinu S, Zavattari P, Casadei-Gardini A. Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters. Eur J Cancer. 2022;175:299–310. https://doi.org/10.1016/j.ejca.2022.08.026.

Article  CAS  PubMed  Google Scholar 

Banales JM, Cardinale V, Macias RIR, Andersen JB, Braconi C, Carpino G, Alvaro D, Calvisi DF. Cholangiocarcinoma: state-of-the-art knowledge and challenges. Liver Int. 2019;39(S1):5–6. https://doi.org/10.1111/liv.14101.

Article  PubMed  Google Scholar 

Salati M, Caputo F, Baldessari C, Carotenuto P, Messina M, Caramaschi S, Dominici M, Bonetti LR. The evolving role of FGFR2 inhibitors in intrahepatic cholangiocarcinoma: from molecular biology to clinical targeting. Cancer Manag Res 2021;13:7747–7757 https://doi.org/10.2147/CMAR.S330710

Franco B, Clarke P, Carotenuto P. Pemigatinib fibroblast growth factor receptor inhibitor treatment of cholangiocarcinoma. Drugs Future 2019;44(12):923 https://doi.org/10.1358/dof.2019.44.12.3010576

Salati M, Braconi C. Noncoding RNA in cholangiocarcinoma. Semin Liver Dis. 2019;39(1):13–25. https://doi.org/10.1055/s-0038-1676097.

Article  CAS  PubMed  Google Scholar 

Previdi MC, Carotenuto P, Zito D, Pandolfo R, Braconi C. Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know? Future Oncol. 2017;13(5):443–53. https://doi.org/10.2217/fon-2016-0253.

Article  CAS  PubMed  Google Scholar 

Prinz C, Frese R, Grams M, Fehring L. Emerging role of MicroRNA dysregulation in diagnosis and prognosis of extrahepatic cholangiocarcinoma. Genes (Basel). 2022. https://doi.org/10.3390/genes13081479.

Article  PubMed  PubMed Central  Google Scholar 

Barbato A, Piscopo F, Salati M, Reggiani-Bonetti L, Franco B, Carotenuto P. Micro-RNA in cholangiocarcinoma: implications for diagnosis, prognosis, and therapy. J Mol Pathol. 2022;3(2):88–103. https://doi.org/10.3390/jmp3020009.

Article  CAS  Google Scholar 

Indrieri A, Carrella S, Carotenuto P, Banfi S, Franco B (2020) The Pervasive Role of the Family in Development Neurodegeneration, and Cancer. Int J Mol Sci 21 (6). Doi:https://doi.org/10.3390/ijms21062092.

Pop-Bica C, Pintea S, Cojocneanu-Petric R, del Sal G, Piazza S, Wu Z-H, Alencar AJ, Lossos IS, Berindan-Neagoe I, Calin GA. MiR-181 family-specific behavior in different cancers: a meta-analysis view. Cancer Metastasis Rev. 2018;37(1):17–32. https://doi.org/10.1007/s10555-017-9714-9.

Article  CAS  PubMed  Google Scholar 

Sun CX, Liu BJ, Su Y, Shi GW, Wang Y, Chi JF. MiR-181a promotes cell proliferation and migration through targeting KLF15 in papillary thyroid cancer. Clin Transl Oncol. 2022;24(1):66–75. https://doi.org/10.1007/s12094-021-02670-1.

Article  CAS  PubMed  Google Scholar 

Barbato A, Iuliano A, Volpe M, D’alterio R, Brillante S, Massa F, De Cegli R, Carrella S, Salati M, Russo A, Russo G, Riccardo S, Cacchiarelli D, Capone M, Madonna G, Ascierto PA, Franco B, Indrieri A, Carotenuto P. Integrated genomics identifies MiR-181/TFAM pathway as a critical driver of drug resistance in melanoma. Int J Mol Sci. 2021. https://doi.org/10.3390/ijms22041801.

Article  PubMed  PubMed Central  Google Scholar 

Jiang Z-L, Zhang F-X, Zhan H-L, Yang H-J, Zhang S-Y, Liu Z-H, Jiang Y, Lv L-Z, Ke R-S. MiR-181b-5p promotes the progression of cholangiocarcinoma by targeting PARK2 via PTEN/PI3K/AKT signaling pathway. Biochem Genet. 2022;60(1):223–40. https://doi.org/10.1007/s10528-021-10084-5.

Article  CAS  PubMed  Google Scholar 

Qin Y, Zheng Y, Huang C, Li Y, Gu M, Wu Q. Downregulation of MiR-181b-5p inhibits the viability, migration, and glycolysis of gallbladder cancer by upregulating PDHX under hypoxia. Front Oncol. 2021;11: 683725. https://doi.org/10.3389/fonc.2021.683725.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han B, Huang J, Han Y, Hao J, Wu X, Song H, Chen X, Shen Q, Dong X, Pang H, Cai L. The MicroRNA MiR-181c enhances chemosensitivity and reduces chemoresistance in breast cancer cells via down-regulating osteopontin. Int J Biol Macromol. 2019;125:544–56. https://doi.org/10.1016/j.ijbiomac.2018.12.075.

Article  CAS  PubMed  Google Scholar 

Shi Y, Li Y, Wu W, Xu B, Ju J. MiR-181d functions as a potential tumor suppressor in oral squamous cell carcinoma by targeting K-Ras. Int J Clin Exp Pathol. 2017;10(7):7847–55.

PubMed  PubMed Central  Google Scholar 

Carotenuto P, Romano A, Barbato A, Quadrano P, Brillante S, Volpe M, Ferrante L, Tammaro R, Morleo M, De Cegli R, Iuliano A, Testa M, Andreone F, Ciliberto G, Clery E, Troncone G, Palma G, Arra C, Barbieri A, Capone M, Madonna G, Ascierto PA, Lanfrancone L, Indrieri A, Franco B. Targeting the MITF/APAF-1 axis as salvage therapy for mapk inhibitors in resistant melanoma. Cell Rep. 2022;41(6): 111601. https://doi.org/10.1016/j.celrep.2022.111601.

Article  CAS  PubMed  Google Scholar 

Carotenuto P, Amato F, Lampis A, Rae C, Hedayat S, Previdi MC, Zito D, Raj M, Guzzardo V, Sclafani F, Lanese A, Parisi C, Vicentini C, Said-Huntingford I, Hahne JC, Hallsworth A, Kirkin V, Young K, Begum R, Wotherspoon A, Kouvelakis K, Azevedo SX, Michalarea V, Upstill-Goddard R, Rao S, Watkins D, Starling N, Sadanandam A, Chang DK, Biankin AV, Jamieson NB, Scarpa A, Cunningham D, Chau I, Workman P, Fassan M, Valeri N, Braconi C. Modulation of pancreatic cancer cell sensitivity to folfirinox through microrna-mediated regulation of DNA damage. Nat Commun. 2021;12(1):6738. https://doi.org/10.1038/s41467-021-27099-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oh D-Y, Ruth He A, Qin S, Chen L-T, Okusaka T, Vogel A, Kim JW, Suksombooncharoen T, Ah Lee M, Kitano M, Burris H, Bouattour M, Tanasanvimon S, McNamara MG, Zaucha R, Avallone A, Tan B, Cundom J, Lee C, Takahashi H, Ikeda M, Chen J-S, Wang J, Makowsky M, Rokutanda N, He P, Kurland JF, Cohen G, Valle JW. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evid. 2022. https://doi.org/10.1056/EVIDoa2200015.

Article  PubMed  Google Scholar 

Lee JW, Son JH, Lee BS, Lee SH, Jang DK, Chung KH, Ryu JK, Kim Y-T. Prognostic value of CA 19–9 kinetics during gemcitabine-based chemotherapy in patients with advanced cholangiocarcinoma. Ann Oncol. 2015;26:vii121. https://doi.org/10.1093/annonc/mdv472.70.

Article  Google Scholar 

Chen Z, Shi H, Sun S, Xu H, Cao D, Luo J. MicroRNA-181b suppresses TAG via target IRS2 and regulating multiple genes in the hippo pathway. Exp Cell Res. 2016;348(1):66–74. https://doi.org/10.1016/j.yexcr.2016.09.004.

Article  CAS  PubMed  Google Scholar 

Schonrock N, Humphreys DT, Preiss T, Götz J. Target gene repression mediated by MiRNAs MiR-181c and MiR-9 both of which are down-regulated by Amyloid-β. J Mol Neurosci. 2012;46(2):324–35. https://doi.org/10.1007/s12031-011-9587-2.

Article  CAS  PubMed  Google Scholar 

Zhang Q, Sun H, Jiang Y, Ding L, Wu S, Fang T, Yan G, Hu Y. MicroRNA-181a suppresses mouse granulosa cell proliferation by targeting activin receptor IIA. PLoS ONE. 2013;8(3): e59667. https://doi.org/10.1371/journal.pone.0059667.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hashimoto Y, Akiyama Y, Otsubo T, Shimada S, Yuasa Y. Involvement of epigenetically silenced MicroRNA-181c in gastric carcinogenesis. Carcinogenesis. 2010;31(5):777–84. https://doi.org/10.1093/carcin/bgq013.

Article  CAS  PubMed  Google Scholar 

She X, Yu Z, Cui Y, Lei Q, Wang Z, Xu G, Luo Z, Li G, Wu M. MiR-181 Subunits enhance the chemosensitivity of temozolomide by Rap1B-Mediated cytoskeleton remodeling in glioblastoma cells. Med Oncol. 2014;31(4):892. https://doi.org/10.1007/s12032-014-0892-9.

Article  CAS  PubMed  Google Scholar 

Zhou H, Yang D, Cheng HS, McCoy MG, Pérez-Cremades D, Haemmig S, Wong D, Chen L, Feinberg MW. MiR-181b regulates vascular endothelial aging by modulating an MAP3K3 signaling pathway. FASEB J. 2022. https://doi.org/10.1096/fj.202200046R.

Article  PubMed  Google Scholar 

Yao L, Wang L, Li F, Gao X, Wei X, Liu Z. MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression. Int J Clin Exp Med. 2015;8(9):15198–205.

CAS  PubMed  PubMed Central  Google Scholar 

Yan X, Huang Y. Mechanism of total glucosides of paeony in hypoxia/reoxygenation-induced cardiomyocyte pyroptosis. J Bioenerg Biomembr. 2021;53(6):643–53. https://doi.org/10.1007/s10863-021-09921-4.

Article  CAS  PubMed  Google Scholar 

Zhou S-F, He S-M, Zeng S, Zhou Z-W, He Z. Hsa-MicroRNA-181a Is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication. Drug Des Devel Ther. 2015. https://doi.org/10.2147/DDDT.S73551.